Table 1 Clinical characteristics of the derivation and validation cohorts.
From: ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population
| Â | Derivation cohort | Validation cohort | P |
|---|---|---|---|
(n = 4800) | (n = 4802) | ||
Age (years) | 48.0 ± 10.2 | 47.9 ± 10.1 | 0.674 |
Sex (male%) | 73.6 | 73.6 | 0.981 |
Height (cm) | 166.60 ± 7.87 | 166.56 ± 7.93 | 0.989 |
Weight (kg) | 68.30 ± 11.24 | 68.33 ± 11.16 | 0.888 |
BMI (kg/m2) | 24.53 ± 3.18 | 24.55 ± 3.13 | 0.756 |
Waist circumference (cm) | 86.32 ± 9.15 | 86.37 ± 9.13 | 0.806 |
SBP (mmHg) | 129.30 ± 18.00 | 128.89 ± 17.56 | 0.264 |
DBP (mmHg) | 79.24 ± 11.53 | 79.13 ± 11.24 | 0.631 |
Heart rate (per min) | 74.21 ± 10.65 | 74.16 ± 10.68 | 0.848 |
Hemoglobin (g/L) | 149.75 ± 15.14 | 149.97 ± 15.68 | 0.487 |
Platelet count (×109) | 206.11 ± 51.04 | 204.46 ± 50.61 | 0.110 |
White blood cell count (×109) | 6.04 ± 1.54 | 6.01 ± 1.53 | 0.364 |
Neutrophil count (×109) | 3.45 ± 1.16 | 3.42 ± 1.15 | 0.235 |
Albumin (g/L) | 46.42 ± 3.13 | 46.33 ± 3.14 | 0.186 |
Globulin (g/L) | 26.25 ± 3.41 | 26.25 ± 3.42 | 0.963 |
Uric acid (μmol/L) | 348.91 ± 86.99 | 347.62 ± 85.55 | 0.463 |
Fasting plasma glucose (mmol/L) | 5.10 ± 1.12 | 5.11 ± 1.23 | 0.604 |
Triglycerides (mmol/L) | 1.69 ± 1.33 | 1.72 ± 1.45 | 0.388 |
Total cholesterol (mmol/L) | 4.79 ± 0.88 | 4.82 ± 0.92 | 0.176 |
LDL-C (mmol/L) | 2.64 ± 0.67 | 2.65 ± 0.68 | 0.320 |
VLDL-C (mmol/L) | 0.94 ± 0.54 | 0.96 ± 0.56 | 0.107 |
HDL-C (mmol/L) | 1.21 ± 0.30 | 1.21 ± 0.30 | 0.268 |
AFU (IU/L) | 27.58 ± 7.79 | 27.55 ± 7.71 | 0.858 |
ALT (IU/L) | 25.94 ± 22.40 | 26.44 ± 7.76 | 0.333 |
AST (IU/L) | 22.87 ± 11.49 | 23.18 ± 16.07 | 0.281 |
GGT (IU/L) | 39.41 ± 59.43 | 39.34 ± 46.94 | 0.948 |
Cholinesterase (IU/L) | 8992 ± 1651 | 9011 ± 1651 | 0.577 |
ALP (IU/L) | 67.80 ± 19.64 | 68.08 ± 19.43 | 0.477 |
AFP (ng/ml) | 2.96 ± 1.72 | 3.07 ± 3.34 | 0.051 |
